Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 7—July 2018

Progress in Vaccine-Preventable and Respiratory Infectious Diseases—First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015

Anne SchuchatComments to Author , Larry J. Anderson1, Lance E. Rodewald, Nancy J. Cox, Rana Hajjeh2, Mark A. Pallansch, Nancy E. Messonnier, Daniel B. Jernigan, and Melinda Wharton
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 2

Selected recommendations of the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, 2005–2015*

New vaccine (indication) Date of ACIP recommendation
Meningococcal ACWY conjugate (adolescents) 2005 Feb
Tdap (adolescents) 2005 Jun
Measles, mumps, rubella, and varicella (MMRV) 2005 Oct
Influenza (24–59-month-old children) 2006 Feb
Rotavirus (infants) 2006 Feb
Human papillomavirus (adolescent girls) 2006 Jun
Second-dose varicella 2006 Jun
Zoster (shingles) 2006 Oct
Influenza (persons 6 mo–18 y of age) 2009 Feb
13-valent pneumococcal conjugate vaccine (children) 2010 Feb
Influenza (universal in persons >6 mo of age) 2010 Feb
Second dose of meningococcal ACWY conjugate (adolescents) 2010 Oct
Human papillomavirus (adolescent boys) 2011 Oct
Tdap (in every pregnant woman) 2012 Oct
13-valent pneumococcal conjugate vaccine (persons >65 years of age) 2014 Aug
Meningococcal B vaccine (during outbreaks and in high-risk persons) 2015 Feb
HPV-9 (adolescents) 2015 Feb
Meningococcal B (adolescents, category B) 2015 Jun

*ACIP, Advisory Committee on Immunization Practices; HPV, human papillomavirus; Tdap, tetanus, diphtheria, and acellular pertussis.

Main Article

1Current affiliation: Emory University, Atlanta, Georgia, USA.

2Current affiliation: World Health Organization, Cairo, Egypt.

Page created: June 18, 2018
Page updated: June 18, 2018
Page reviewed: June 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.